| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
The Vanguard Group, Inc.
|
159.879k | 2.72% | +63.718k | Dec 31 2025 |
| 2 |
Bhat (Laxminarayan)
|
124.212k | 2.12% | — | Oct 21 2025 |
| 3 |
Millennium Management LLC
|
113.174k | 1.93% | +27.613k | Dec 31 2025 |
| 4 |
Vedanta Partners LLC
|
71.477k | 1.22% | — | Dec 18 2025 |
| 5 |
Geode Capital Management, L.L.C.
|
52.448k | 0.89% | +24.486k | Dec 31 2025 |
|
1
The Vanguard Group, Inc.
|
2.72%
159.879k
|
|
2
Bhat (Laxminarayan)
|
2.12%
124.212k
|
|
3
Millennium Management LLC
|
1.93%
113.174k
|
|
4
Vedanta Partners LLC
|
1.22%
71.477k
|
|
5
Geode Capital Management, L.L.C.
|
0.89%
52.448k
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 8.88% of Reviva Pharmaceuticals Holdings Inc., with The Vanguard Group, Inc. the biggest at 2.72%, followed by Bhat (Laxminarayan) (2.12%) and Millennium Management LLC (1.93%). |
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in Reviva Pharmaceuticals Holdings Inc. has fallen over the past 12 months from around 21.3% to 15.0% of the float. Fewer and fewer market participants are betting on falling prices. That points to easing skepticism, as short sellers increasingly unwind their positions. |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


